What is Toviaz?
Toviaz is a medication used to treat the symptoms of overactive bladder (OAB). Its active ingredient, fesoterodine, works by relaxing the muscles in the bladder, reducing the frequent urge to urinate and incontinence. Toviaz is available in tablet form and is taken by mouth once a day.
Toviaz was developed by Pfizer, which holds the patent for the drug. The medication was first approved by the United States Food and Drug Administration (FDA) in 2008 for the treatment of OAB in adults , and has since been approved in many other countries. Toviaz is also marketed under other brand names, such as Generess.
The recommended dose of Toviaz is 4 to 8 mg once daily , and it is available in tablets of 4 and 8 mg. Toviaz should be taken with water and can be taken with or without food. Patients with kidney or liver problems may need to take a lower dose of Toviaz.
Common side effects of Toviaz include dry mouth, constipation, blurred vision, and urinary tract infections. Serious side effects, such as difficulty breathing, severe stomach pain, and allergic reactions, are rare but should be reported to a healthcare professional immediately.
In summary, Toviaz is a medication used to treat OAB symptoms, such as frequent urination, by relaxing the bladder muscles. It is available in tablet form and typically taken once a day. While Toviaz can be associated with some side effects, it is generally safe and effective in controlling OAB symptoms.
Frequently Asked Questions about toviaz
Toviaz (fesoterodine) is used for overactive bladder (OAB) symptoms such as loss of bladder control, urinary urgency, and frequency. It works similarly to other OAB medications, such as oxybutynin, and has fewer side effects but it is more expensive.
TOVIAZ® (fesoterodine fumarate) | Pfizer Medical Information - US.
Toviaz has an average rating of 5.2 out of 10 from a total of 73 reviews on Drugs.com. 32% of reviewers reported a positive experience, while 37% reported a negative experience.
Myrbetriq (mirabegron) and Toviaz (fesoterodine fumarate) are used to treat overactive bladder (OAB) with symptoms of urge urinary incontinence, urgency, and urinary frequency. Myrbetriq and Toviaz belong to different drug classes. Myrbetriq is a beta-3 adrenergic agonist and Toviaz is a muscarinic receptor antagonist.
The adverse events observed during long-term, open-label studies were similar to those observed in the 12-week, placebo-controlled studies, and included dry mouth, constipation, dry eyes, dyspepsia, and abdominal pain.
blurred vision; weight gain; dry mouth; or. stomach pain, diarrhea, constipation.
Development timeline for Toviaz
| Date | Article |
|---|
| Oct 31, 2008 | Approval Pfizer's Toviaz (fesoterodine fumarate) Receives FDA Approval for the Treatment of Overactive Bladder |
This is a brand name drug and a generic may be available. The average cost for 30 Tablet Extended Release 24 Hour(s), 8mg each of the generic (fesoterodine fumarate er) is $393.79. You can buy fesoterodine fumarate er at the discounted price of $35.92 by using the WebMDRx coupon, a savings of 91%.
Toviaz has an average rating of 4.9 out of 10 from a total of 55 reviews for the treatment of Urinary Frequency. 27% of reviewers reported a positive experience, while 40% reported a negative experience.
Heart conditions: The symptoms of heart disease, heart failure, abnormal heart rhythms or heart rate, and high blood pressure can be aggravated by fesoterodine.
As many as 78% of the patients who start these medications stop taking them within a year. But medication is only one part of the treatment equation for overactive bladder. If your first (or even your fourth or fifth) medication isn't working for you, there are still other treatments to explore.
Behavioral interventions are the first choice in helping manage an overactive bladder. They're often effective, and they carry no side effects. Behavioral interventions may include: Pelvic floor muscle exercises.
Dry mouth, dry eyes, constipation, dizziness, drowsiness, or blurred vision may occur. If any of these effects last or get worse, notify your doctor or pharmacist promptly. To relieve dry mouth, suck on (sugarless) hard candy or ice chips, chew (sugarless) gum, drink water or use a saliva substitute.
A reduction in number of urge urinary incontinence episodes per 24 hours was observed for both doses as compared to placebo as early as two weeks after starting Toviaz therapy. Toviaz is indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency, and frequency.
